RU2014139857A - Полипептиды и их применение - Google Patents
Полипептиды и их применение Download PDFInfo
- Publication number
- RU2014139857A RU2014139857A RU2014139857A RU2014139857A RU2014139857A RU 2014139857 A RU2014139857 A RU 2014139857A RU 2014139857 A RU2014139857 A RU 2014139857A RU 2014139857 A RU2014139857 A RU 2014139857A RU 2014139857 A RU2014139857 A RU 2014139857A
- Authority
- RU
- Russia
- Prior art keywords
- malassezia
- spp
- polypeptide
- paragraphs
- sequence
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title claims abstract 29
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract 29
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract 29
- 241000555676 Malassezia Species 0.000 claims abstract 32
- 206010017533 Fungal infection Diseases 0.000 claims abstract 14
- 208000031888 Mycoses Diseases 0.000 claims abstract 14
- 241001291475 Malassezia slooffiae Species 0.000 claims abstract 12
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims abstract 12
- 206010016936 Folliculitis Diseases 0.000 claims abstract 8
- 241000101040 Pityriasis Species 0.000 claims abstract 8
- 150000001413 amino acids Chemical class 0.000 claims abstract 8
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract 7
- 206010000496 acne Diseases 0.000 claims abstract 7
- 208000001840 Dandruff Diseases 0.000 claims abstract 6
- 241000555688 Malassezia furfur Species 0.000 claims abstract 6
- 241001299738 Malassezia pachydermatis Species 0.000 claims abstract 6
- 244000053095 fungal pathogen Species 0.000 claims abstract 6
- 208000015181 infectious disease Diseases 0.000 claims abstract 6
- 201000004624 Dermatitis Diseases 0.000 claims abstract 5
- 208000004396 mastitis Diseases 0.000 claims abstract 5
- 206010053555 Arthritis bacterial Diseases 0.000 claims abstract 4
- 206010011844 Dacryocystitis Diseases 0.000 claims abstract 4
- 206010012438 Dermatitis atopic Diseases 0.000 claims abstract 4
- 208000007514 Herpes zoster Diseases 0.000 claims abstract 4
- 208000004575 Infectious Arthritis Diseases 0.000 claims abstract 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000004472 Lysine Substances 0.000 claims abstract 4
- 201000004681 Psoriasis Diseases 0.000 claims abstract 4
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims abstract 4
- 201000008937 atopic dermatitis Diseases 0.000 claims abstract 4
- 208000010217 blepharitis Diseases 0.000 claims abstract 4
- 206010033072 otitis externa Diseases 0.000 claims abstract 4
- 208000003154 papilloma Diseases 0.000 claims abstract 4
- 208000029211 papillomatosis Diseases 0.000 claims abstract 4
- 208000008742 seborrheic dermatitis Diseases 0.000 claims abstract 4
- 201000001223 septic arthritis Diseases 0.000 claims abstract 4
- 201000009890 sinusitis Diseases 0.000 claims abstract 4
- 241001291474 Malassezia globosa Species 0.000 claims abstract 3
- 241001048957 Malassezia nana Species 0.000 claims abstract 3
- 241001350514 Malassezia yamatoensis Species 0.000 claims abstract 3
- 241001465754 Metazoa Species 0.000 claims abstract 3
- 108010039918 Polylysine Proteins 0.000 claims abstract 3
- 206010034674 peritonitis Diseases 0.000 claims abstract 3
- 229920000656 polylysine Polymers 0.000 claims abstract 3
- 230000002265 prevention Effects 0.000 claims abstract 3
- 206010040872 skin infection Diseases 0.000 claims abstract 3
- 241001291477 Malassezia restricta Species 0.000 claims abstract 2
- 244000184734 Pyrus japonica Species 0.000 claims abstract 2
- 206010037888 Rash pustular Diseases 0.000 claims abstract 2
- 208000029561 pustule Diseases 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 9
- 229940121375 antifungal agent Drugs 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000000843 anti-fungal effect Effects 0.000 claims 3
- 239000003429 antifungal agent Substances 0.000 claims 3
- 210000004761 scalp Anatomy 0.000 claims 3
- 108010049047 Echinocandins Proteins 0.000 claims 2
- 206010017523 Fungaemia Diseases 0.000 claims 2
- -1 coumarin compound Chemical class 0.000 claims 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 claims 1
- 244000291564 Allium cepa Species 0.000 claims 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 claims 1
- 241000428512 Malassezia dermatis Species 0.000 claims 1
- 241000271955 Malassezia japonica Species 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 229930013930 alkaloid Natural products 0.000 claims 1
- 150000003851 azoles Chemical class 0.000 claims 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 1
- 229960000956 coumarin Drugs 0.000 claims 1
- 235000001671 coumarin Nutrition 0.000 claims 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 claims 1
- 229940093496 esculin Drugs 0.000 claims 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000002989 phenols Chemical class 0.000 claims 1
- 150000004291 polyenes Chemical class 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 229930182490 saponin Natural products 0.000 claims 1
- 150000007949 saponins Chemical class 0.000 claims 1
- 235000017709 saponins Nutrition 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 229940043810 zinc pyrithione Drugs 0.000 claims 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Polyamides (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1204457.4 | 2012-03-14 | ||
| GBGB1204457.4A GB201204457D0 (en) | 2012-03-14 | 2012-03-14 | Polypeptides and their use |
| US201261620833P | 2012-04-05 | 2012-04-05 | |
| US61/620,833 | 2012-04-05 | ||
| PCT/GB2013/000112 WO2013136040A1 (en) | 2012-03-14 | 2013-03-14 | Polypeptides and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014139857A true RU2014139857A (ru) | 2016-05-10 |
Family
ID=46026493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014139857A RU2014139857A (ru) | 2012-03-14 | 2013-03-14 | Полипептиды и их применение |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20140155321A1 (enExample) |
| EP (1) | EP2825261A1 (enExample) |
| JP (1) | JP2015516943A (enExample) |
| KR (1) | KR20140138940A (enExample) |
| CN (1) | CN104428036A (enExample) |
| AU (1) | AU2013234122A1 (enExample) |
| CA (1) | CA2866837A1 (enExample) |
| CL (1) | CL2014002397A1 (enExample) |
| GB (1) | GB201204457D0 (enExample) |
| HK (1) | HK1201050A1 (enExample) |
| IL (1) | IL234646A0 (enExample) |
| MX (1) | MX2014010996A (enExample) |
| NZ (1) | NZ700467A (enExample) |
| RU (1) | RU2014139857A (enExample) |
| SG (1) | SG11201405539QA (enExample) |
| WO (1) | WO2013136040A1 (enExample) |
| ZA (1) | ZA201407276B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2981037C (en) * | 2015-04-03 | 2019-04-30 | Elc Management Llc | Hair treatment compositions comprising hydrolyzed wheat protein and polyquaternium-6 |
| JP6553961B2 (ja) * | 2015-06-25 | 2019-07-31 | 花王株式会社 | 美白剤 |
| WO2017047299A1 (ja) * | 2015-09-15 | 2017-03-23 | 富士フイルム株式会社 | 注射用液剤組成物 |
| CN109700834A (zh) * | 2019-01-18 | 2019-05-03 | 上海市农业科学院 | 一种蛹虫草固体发酵物及其抗菌用途 |
| AR122485A1 (es) | 2020-06-04 | 2022-09-14 | Syngenta Crop Protection Ag | Composiciones fungicidas |
| CN115381928B (zh) * | 2022-10-27 | 2022-12-27 | 山东中医药大学附属医院 | 一种真菌提取物在制备溃疡性结肠炎治疗药物中的应用 |
| JP2024082709A (ja) * | 2022-12-09 | 2024-06-20 | 日本メナード化粧品株式会社 | 抗菌剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1927597T3 (en) * | 2004-08-18 | 2017-02-13 | Novabiotics Ltd | ANTIBACTERIAL PEPTIDES |
| GB0611115D0 (en) * | 2006-06-06 | 2006-07-19 | Novabiotics Ltd | Compounds and their use |
| GB0702020D0 (en) * | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| GB0702022D0 (en) * | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
| EP2224901A1 (en) * | 2007-12-21 | 2010-09-08 | Basf Se | Anti-dandruff compositions containing peptides |
-
2012
- 2012-03-14 GB GBGB1204457.4A patent/GB201204457D0/en not_active Ceased
-
2013
- 2013-03-14 NZ NZ700467A patent/NZ700467A/en not_active IP Right Cessation
- 2013-03-14 JP JP2014561504A patent/JP2015516943A/ja active Pending
- 2013-03-14 MX MX2014010996A patent/MX2014010996A/es unknown
- 2013-03-14 SG SG11201405539QA patent/SG11201405539QA/en unknown
- 2013-03-14 HK HK15101528.2A patent/HK1201050A1/xx unknown
- 2013-03-14 KR KR1020147028818A patent/KR20140138940A/ko not_active Withdrawn
- 2013-03-14 US US14/004,344 patent/US20140155321A1/en not_active Abandoned
- 2013-03-14 AU AU2013234122A patent/AU2013234122A1/en not_active Abandoned
- 2013-03-14 WO PCT/GB2013/000112 patent/WO2013136040A1/en not_active Ceased
- 2013-03-14 EP EP13718609.4A patent/EP2825261A1/en not_active Ceased
- 2013-03-14 CN CN201380014410.5A patent/CN104428036A/zh active Pending
- 2013-03-14 RU RU2014139857A patent/RU2014139857A/ru not_active Application Discontinuation
- 2013-03-14 CA CA2866837A patent/CA2866837A1/en not_active Abandoned
-
2014
- 2014-09-10 CL CL2014002397A patent/CL2014002397A1/es unknown
- 2014-09-14 IL IL234646A patent/IL234646A0/en unknown
- 2014-10-07 ZA ZA2014/07276A patent/ZA201407276B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2866837A1 (en) | 2013-09-19 |
| HK1201050A1 (en) | 2015-08-21 |
| EP2825261A1 (en) | 2015-01-21 |
| CL2014002397A1 (es) | 2015-02-27 |
| IL234646A0 (en) | 2014-11-30 |
| US20140155321A1 (en) | 2014-06-05 |
| WO2013136040A1 (en) | 2013-09-19 |
| CN104428036A (zh) | 2015-03-18 |
| KR20140138940A (ko) | 2014-12-04 |
| AU2013234122A1 (en) | 2014-10-16 |
| SG11201405539QA (en) | 2014-10-30 |
| GB201204457D0 (en) | 2012-04-25 |
| JP2015516943A (ja) | 2015-06-18 |
| NZ700467A (en) | 2016-08-26 |
| ZA201407276B (en) | 2015-06-24 |
| MX2014010996A (es) | 2014-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11224599B2 (en) | Therapeutic agents and methods | |
| BR112013029692A2 (pt) | derivados de imidazol úteis para o tratamento da artrite | |
| EA201490396A1 (ru) | Ингибиторы репликации вирусов гриппа | |
| BR112013014184A2 (pt) | compostos de triazina [1,2,4] triazolo [4,3-b][1,2,4], método de preparo e seu uso | |
| WO2018128678A3 (en) | Compositions and methods for restructuring chemically treated hair | |
| PH12017500136A1 (en) | Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof | |
| EA201591512A1 (ru) | Борсодержащие молекулы, способы и составы | |
| MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
| RU2013113184A (ru) | Комбинированное лечение розацеа | |
| WO2015104292A3 (en) | Compounds for use in treating or preventing cancerous diseases | |
| Domalaon et al. | Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria: R. Domalaon et al. | |
| US20230382945A1 (en) | Therapeutic agents and methods | |
| WO2008036761A3 (en) | Anti-microbial defensin-related peptides and methods of use | |
| MX2014010996A (es) | Polipeptidos y su uso. | |
| CR9991A (es) | Nuevo derivado de pleuromutilina y su uso | |
| MX377333B (es) | Peptidos derivados de ezrina y composiciones farmaceuticas de los mismos. | |
| WO2009106715A3 (fr) | Peptide derive d'une proteine de la famille des aquaporines | |
| CL2007003344A1 (es) | Compuestos derivados de pirimidilmetil-sulfonamida; proceso para preparar dichos compuestos; composicion agricola; metodo para el tratamiento de hongos fitopatogenos daninos; uso de dichos compuestos; metodo para combatir plagas de artropodos, metodo | |
| EA201992587A1 (ru) | Пептиды и их применение в качестве противовирусных агентов | |
| BR112018076229A2 (pt) | formulação tópica e método de tratamento da pele seca pruriginosa causada por ureia de um indivíduo | |
| RU2020119597A (ru) | Композиция для лечения пациента с респираторным заболеванием, обусловленным хроническим воспалением, способ получения и применение указанной композиции | |
| WO2022256394A3 (en) | Selective small molecule agonists and partial agonists of trk receptors | |
| UY28543A1 (es) | Mezclas fungicidas para combatir patógenos del arroz | |
| CO6640307A2 (es) | Derivados de flufenoxina para el tratamiento y la prevención de patologías amiloides | |
| KR20240070659A (ko) | 항미생물 화합물 및 사용 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20170703 |